¶óÆæÆ®¦¢Ä«Æä¦¢ºí·Î±×¦¢´õº¸±â
¾ÆÄ«µ¥¹Ì Ȩ ¸í»çƯ°­ ´ëÇבּ¸½Ç޹æ Á¶°æ½Ç¹« µ¿¿µ»ó°­ÀÇ Çѱ¹ÀÇ ÀüÅëÁ¤¿ø ÇÐȸº° ³í¹®
ÇÐȸº° ³í¹®

Çѱ¹°Ç¼³°ü¸®ÇÐȸ
Çѱ¹°ÇÃà½Ã°øÇÐȸ
Çѱ¹µµ·ÎÇÐȸ
Çѱ¹»ý¹°È¯°æÁ¶ÀýÇÐȸ
Çѱ¹»ýÅÂÇÐȸ
Çѱ¹¼öÀÚ¿øÇÐȸ
Çѱ¹½Ä¹°ÇÐȸ
Çѱ¹½Ç³»µðÀÚÀÎÇÐȸ
Çѱ¹ÀÚ¿ø½Ä¹°ÇÐȸ
Çѱ¹ÀܵðÇÐȸ
Çѱ¹Á¶°æÇÐȸ
Çѱ¹Áö¹Ý°øÇÐȸ
Çѱ¹ÇÏõȣ¼öÇÐȸ
Çѱ¹È¯°æ»ý¹°ÇÐȸ
Çѱ¹È¯°æ»ýÅÂÇÐȸ

Çѱ¹È¯°æ»ý¹°ÇÐȸ / v.18, no.1, 2000³â, pp.41-45
Ä«µå¹Å Àü󸮿¡ ÀÇÇÑ »ýÁãÀÇ Ä«µå¹Å Ä¡»ç ¿ÏÈ­È¿°ú¿Í °£ glutathione ÇÔ·®°úÀÇ »ó°ü¼º
( Is Cadmium Pretreatment-Induced Protection against Cadmium Lethality to Mice Related to the Hepatic Glutathione Contentsulcorner )
ºÎ¹®Á¾; »ïÀ°´ëÇб³ »ý¹°Çаú;
 
ÃÊ ·Ï
»ýÁã¿¡¼­ Ä«µå¹Å Àü 󸮿¡ ÀÇÇÏ¿© Ä«µå¹ÅÀÇ Ä¡»çµ¶¼ºÀÌ ¿ÏÈ­µÇ´ÂÁö¸¦ Á¶»çÇϰí Ä¡»ç¿ÏÈ­ È¿°ú¿Í °£ Á¶Á÷³»ÀÇ glutathione(GSH)ÇÔ·®ÀÌ »ó°ü¼ºÀÌ ÀÖ´ÂÁö¸¦ Á¶»çÇÏ¿´´Ù. Ä¡»ç·®ÀÇ Ä«µå¹ÅÀ» ÁÖ»çÇϱâ Àü¿¡ Ä¡»ç·® ÀÌÇÏÀÇ Ä«µå¹ÅÀ» ÁÖ»çÇϸé Ä¡»ç·®ÀÇ Ä«µå¹Å¿¡ ÀÇÇÑ Ä¡»çÀÛ¿ëÀÌ ¿ÏÈ­µÇ´Â È¿°ú°¡ ³ªÅ¸³µÀ¸¸ç Ä«µå¹ÅÀÇ Àü ó¸®ÀÇ °æ°ú½Ã°£Àº 48½Ã°£ÀÇ °æ¿ì¿¡, Àü 󸮷®Àº üÁß kg´ç 40$mu$molesÀ» ÁÖ»çÇÑ °æ¿ì¿¡ È¿°ú°¡ °¡Àå ÁÁ¾Ò´Ù. Ä«µå¹ÅÀ» Àü ó¸®ÇÑ »ýÁã´Â Ä«µå¹Å¿¡ ÀÇÇØ Ä¡»çµÇ´Â °æ¿ì¿¡µµ ±× »ýÁ¸±â°£ÀÌ ÃÖ´ë 72½Ã°£±îÁö ¿¬ÀåµÇ¾ú´Ù. Ä¡»ç·®ÀÇ Ä«µå¹ÅÀ» ÁÖ»çÇÑ °æ¿ì¿¡ Ä«µå¹Å Àü 󸮿¡ ÀÇÇÏ¿© »ýÁ¸ÇÑ °³Ã¼µéÀº °£Á¶Á÷³»ÀÇ glutathioneÇÔ·®Àº ´ëÁ¶±º¿¡ ºñÇÏ¿© º°´Ù¸¥ Â÷À̰¡ ¾ø¾úÀ¸³ª Ä¡»çÇÑ °³Ã¼µéÀº glutathione ÇÔ·®ÀÌ °¨¼ÒÇÏ¿´°í ¶ÇÇÑ Àü󸮸¦ ÇÏÁö ¾ÊÀº ½ÇÇ豺Àº Ä¡»ç·®ÀÇ Ä«µå¹Å¿¡ ÀÇÇÏ¿© glutathione ÇÔ·®ÀÌ °¨¼ÒÇÏ¿´´Ù. ÀÌ·¯ÇÑ ½ÇÇè°á°ú´Â Ä¡»ç·® ÀÌÇÏÀÇ Ä«µå¹ÅÀ» »ýÁã¿¡ Àü ó¸®Çϸé Ä¡»çÀÛ¿ëÀ» ¿ÏÈ­ÇÏ´Â ÀÎÀÚµéÀÌ À¯µµµÇ¾î ÈÄ¼Ó ÁÖ»çÇÏ´Â Ä¡»ç·®ÀÇ Ä«µå¹Å¿¡ ÀÇÇÑ Ä¡»çÀÛ¿ëÀ» ¿ÏÈ­Çϰí, °£ Á¶Á÷³»ÀÇ glutathioneÀÌ Ä«µå¹Å Ä¡»çÀÛ¿ë¿¡ ´ëÇÑ ¹æ¾îÀÎÀÚ°¡ µÉ ¼ö ÀÖÀ½À» ¾Ï½ÃÇÑ´Ù.
Which sublethal cadmium pretreatment may prevent from lethal cadmium's killing mice and which cadmium pretreatment-induced protection against cadmium lethality to mice may be related with their hepatic glutathione contents were investigated. When cadmium chloride was subcutaneously injected to mice (ICR strain) at various doses, all mice died, which treated with cadmium at dose of 300 $mu$moles/kg or more, and none died, which treated with cadmium at dose of 80 $mu$moles/kg or less. Subcutaneous pretreatment of sublethal cadmium decreased sacrifice of mice which subsequently injected with lethal cadmium, with most effectiveness at pretreatment dose of cadmium of 40 $mu$moles/kg b.w. and at 48 hours of interval between sublethal cadmium pretreatment and lethal cadmium treatment. Even if a great part of the cadmium-pretreated mice were sacrificed while treated with lethal cadmium, they survived longer than the non-pretreated mice. Sublethal cadmium pretreatment (40 $mu$moles/kg b.w.) 48 hours before lethal cadmium treatment to mice didn't decrease hepatic glutathione contents of the survived mice, while decreases in the glutathione in livers were observed in the mice just after died. These results indicate that sublethal cadmium pretreatment-induced protection against cadmium lethality to mice may be related to their hepatic glutathione contents. [Cd pretreatment, Cd lethality, Hepatic glutathione contents].
 
Ű¿öµå
 
ȯ°æ»ý¹° / v.18, no.1, 2000³â, pp.41-45
Çѱ¹È¯°æ»ý¹°ÇÐȸ
ISSN : 1226-9999
UCI : G100:I100-KOI(KISTI1.1003/JNL.JAKO200011921491582)
¾ð¾î : Çѱ¹¾î
³í¹® Á¦°ø : KISTI Çѱ¹°úÇбâ¼úÁ¤º¸¿¬±¸¿ø
¸ñ·Ïº¸±â
ȸ»ç¼Ò°³ ±¤°í¾È³» ÀÌ¿ë¾à°ü °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ Ã¥ÀÓÀÇ ÇѰè¿Í ¹ýÀû°íÁö À̸ÞÀÏÁÖ¼Ò ¹«´Ü¼öÁý °ÅºÎ °í°´¼¾ÅÍ
   

ÇÏÀ§¹è³ÊÀ̵¿